Media Advisory: Join Hon Moridi and executives of Nordion and Bruce Power for an announcement important to the medical community

OTTAWA, Oct. 22, 2015 /CNW/ - Nordion Inc., Bruce Power and Hon Reza Moridi invite members of the media to hear an announcement important to the medical community.

When:  Tuesday, October 27, 2015

Time:  9-10 a.m. including refreshments

Where:  Princess Margaret Cancer Centre
              7th Floor Research Atrium
              610 University Avenue
              Toronto, ON M5G 2M9

Speakers:  

• Hon Reza Moridi, Minister of Research and Innovation and Minister of Training, Colleges and Universities
• Scott McIntosh, President, Gamma Technologies & Corporate Services, Nordion
• Duncan Hawthorne, President and CEO, Bruce Power
• Dr. Norm Laperriere, Radiation Oncologist, Princess Margaret Cancer Centre

Why: With the expected shutdown of the National Research Universal (NRU) reactor in March 2018, Nordion and Bruce Power will make an announcement about a new Canadian supply of High Specific Activity ("HSA") Cobalt-60. Medical-grade Cobalt is used worldwide for cancer treatment and as an alternative to traditional brain surgery and whole brain radiation therapy for the treatment of complex, difficult brain conditions.

Did You Know?

• Every day 27 Canadians are diagnosed with a brain tumour (source)
• Approximately 55,000 Canadians are surviving with a brain tumour (source)

RSVP: Due to the location of the event, media is asked to confirm their attendance in advance by contacting:  Shelley Maclean, Director, Communications and Government Relations, Nordion [phone] x.2414, [email protected]. We will provide attending media with directions.

Interviews: The following persons are available for interviews: Dr. Laperriere, Scott McIntosh, Duncan Hawthorne and Hon Moridi. Please arrange interviews in advance by contacting Shelley Maclean, Director, Communications and Government Relations, Nordion [phone] x.2414, [email protected].

About Nordion (Canada) Inc.
Nordion provides market-leading products used for the prevention, diagnosis and treatment of disease. We are a leading provider of medical isotopes and gamma technologies that benefit the lives of millions of people around the world. Our products are used daily by pharmaceutical and biotechnology companies, medical-device manufacturers, hospitals, clinics and research laboratories. Nordion supplies products to approximately 500 customers across more than 40 countries around the globe, and is a standalone business within Sterigenics International LLC, the global leader in outsourced contract sterilization services, gamma technologies and medical isotopes. Find out more about Nordion at www.nordion.com and follow us at twitter.com/NordionInc.

About Bruce Power
Bruce Power operates the world's largest operating nuclear generating facility and is the source of roughly 25 per cent of Ontario's electricity. The company's site in Tiverton, Ontario is home to eight CANDU reactors, each one capable of generating enough low-cost, reliable, safe and clean electricity to meet the annual needs of a city the size of Hamilton. Formed in 2001, Bruce Power is an all-Canadian partnership among TransCanada, Borealis Infrastructure Management (a division of the Ontario Municipal Employees Retirement System) as well as the Power Workers' Union and Society of Energy Professionals. A majority of Bruce Power's employees are also owners in the business.

SOURCE Bruce Power

Shelley Maclean, Director, Communications and Government Relations, Nordion [phone] x.2414, [email protected]